Biotech Values

[DewDiligence]

Re: MNTA price action and rumor

Maybe BS, but certainly persistent.

Agreed—the stock held up rather well for a false rumor. Still, if we analyze this piece by piece, the BS angle seems most likely, IMO.

A buyout is possible, but the thread with rkrw points out why now is not the most logical time for this to occur.

If there were a leak that the FDA was about to approve the Lovenox ANDA, the stock would probably have run considerably higher than 11, so it’s probably not that.

Nothing newsworthy is happening on the Copaxone program, which is in litigation with Teva.

Craig Wheeler has plainly stated that M118 will not be partnered until after the phase-2 results are available, so it’s probably not that.

A partnership for the proprietary heparin-derived cancer drug is not totally out of the question, but this program is very early and probably not ready for dealing.

What does that leave? Mainly the rumor is BS vig.